Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patientsReportar como inadecuado

Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Journal of Inflammation

, 5:19

First Online: 03 November 2008Received: 27 July 2008Accepted: 03 November 2008


BackgroundCoeliac disease CD is an enteropathy characterized by an aberrant immune response to cereal-gluten proteins. Although gluten peptides and microorganisms activate similar pro-inflammatory pathways, the role the intestinal microbiota may play in this disorder is unknown. The purpose of this study was to assess whether the faecal microbiota of coeliac patients could contribute to the pro-inflammatory milieu characteristic of CD and the possible benefits of bifidobacteria.

MethodsThe effect of faeces of 26 CD patients with active disease mean age 5.5 years, range 2.1–12.0 years, 18 symptom-free coeliac disease SFCD patients mean age 5.5 years, range 1.0–12.3 years on a gluten-free diet for 1–2 years; and 20 healthy children mean age 5.3 years, range 1.8–10.8 years on induction of cytokine production and surface antigen expression in peripheral blood mononuclear cells PBMCs were determined. The possible regulatory roles of Bifidobacterium longum ES1 and B. bifidum ES2 co-incubated with faecal samples were also assessed in vitro.

ResultsFaeces of both active CD and SFCD patients, representing an imbalanced microbiota, significantly increased TNF-α production and CD86 expression in PBMCs, while decreased IL-10 cytokine production and CD4 expression compared with control samples. Active CD-patient samples also induced significantly higher IFN-γ production compared with controls. However, Bifidobacterium strains suppressed the pro-inflammatory cytokine pattern induced by the large intestinal content of CD patients and increased IL-10 production. Cytokine effects induced by faecal microbiota seemed to be mediated by the NFκB pathway.

ConclusionThe intestinal microbiota of CD patients could contribute to the Th1 pro-inflammatory milieu characteristic of the disease, while B. longum ES1 and B. bifidum ES2 could reverse these deleterious effects. These findings hold future perspectives of interest in CD therapy.

AbbreviationsCDcoeliac disease

DCdendritic cells

IFN-γinterferon gamma


NF-κnuclear factor kappa

PBMCsperipheral blood mononuclear cells

SFCD patientsymptom-free CD patient

TNF-αtumour necrosis factor alpha.

Electronic supplementary materialThe online version of this article doi:10.1186-1476-9255-5-19 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Marcela Medina - Giada De Palma - Carmen Ribes-Koninckx - Miguel Calabuig - Yolanda Sanz


Documentos relacionados